Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec;8(Suppl 6):S580-S584.
doi: 10.21037/tcr.2019.11.16.

Pseudoprogression in low-grade glioma

Jason M Slater  1 , Helen A Shih  1
Affiliations
Editorial

Pseudoprogression in low-grade glioma

Jason M Slater et al. Transl Cancer Res. 2019 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Helen A. Shih: prIME Oncology (educational speaker), UpToDate (Writer), Cleveland Clinic (expert testimony). The other author has no conflicts of interest to declare.

Comment on

References

    1. Brandsma D, Stalpers L, Taal W, et al. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. The Lancet Oncology 2008;9:453-61. 10.1016/S1470-2045(08)70125-6 - DOI - PubMed
    1. Hoffman WF, Levin VA, Wilson CB. Evaluation of malignant glioma patients during the postirradiation period. J Neurosurg 1979;50:624-8. 10.3171/jns.1979.50.5.0624 - DOI - PubMed
    1. de Wit MC, de Bruin HG, Eijkenboom W, et al. Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology 2004;63:535-7. 10.1212/01.WNL.0000133398.11870.9A - DOI - PubMed
    1. Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010;28:1963-72. 10.1200/JCO.2009.26.3541 - DOI - PubMed
    1. Ludmir EB, Mahajan A, Paulino AC, et al. Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy. Neuro Oncol 2019;21:686-95. 10.1093/neuonc/noz042 - DOI - PMC - PubMed